James Mulay, Director at CG Oncology, Inc. (CGON), sold 15,600 shares at $73.01 ($1.1M) on 2026-04-17, disclosed to the SEC on 2026-04-20.
Scheduled sale ($1.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CGON | SELL | 2026-03-17 | $125K | — | Filing → |
| CGON | SELL | 2026-01-13 | $585K | — | Filing → |
| CGON | SELL | 2025-10-10 | $519K | — | Filing → |